|
C18ORF32 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.197100E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.960300E-02 |
| Normal-vs-Stage2 |
5.452800E-01 |
| Normal-vs-Stage3 |
5.93899999999925E-05 |
| Normal-vs-Stage4 |
9.71229999757739E-08 |
| Stage1-vs-Stage2 |
1.155620E-02 |
| Stage1-vs-Stage3 |
5.764600E-03 |
| Stage1-vs-Stage4 |
1.51916999999724E-05 |
| Stage2-vs-Stage3 |
3.595500E-04 |
| Stage2-vs-Stage4 |
3.81329999998847E-06 |
| Stage3-vs-Stage4 |
1.089400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.169300E-04 |
| Normal-vs-AfricanAmerican |
3.264100E-02 |
| Normal-vs-Asian |
2.919300E-03 |
| Caucasian-vs-AfricanAmerican |
9.647400E-01 |
| Caucasian-vs-Asian |
9.650600E-01 |
| AfricanAmerican-vs-Asian |
9.432200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.581700E-03 |
| Normal-vs-Female |
9.361700E-03 |
| Male-vs-Female |
1.876780E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.175920E-02 |
| Normal-vs-Age(41-60Yrs) |
2.756100E-03 |
| Normal-vs-Age(61-80Yrs) |
1.363770E-01 |
| Normal-vs-Age(81-100Yrs) |
3.415800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.985000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.595400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.437400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.055230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.505200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.262970E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.699500E-03 |
| Classical-VS-Follicular |
2.01480054862202E-10 |
| Classical-VS-Other |
4.702800E-01 |
| Classical-VS-Normal |
5.85579999999863E-05 |
| Tall-VS-Follicular |
6.56186216474453E-12 |
| Tall-VS-Other |
3.388400E-01 |
| Tall-VS-Normal |
5.37799999977828E-07 |
| Follicular-VS-Other |
3.86599999999682E-05 |
| Follicular-VS-Normal |
1.756340E-02 |
| Other-VS-Normal |
3.141900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.545840E-01 |
| Normal-vs-N1 |
1.79580999999374E-05 |
| N0-vs-N1 |
2.394600E-04 |
|
|
